Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10962Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Johnson, Paul D R | - |
| dc.date.accessioned | 2015-05-16T00:32:25Z | |
| dc.date.available | 2015-05-16T00:32:25Z | |
| dc.date.issued | 2010-02-03 | - |
| dc.identifier.citation | Lancet (london, England) 2010; 375(9715): 618-9 | en_US |
| dc.identifier.other | PUBMED | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10962 | en |
| dc.language.iso | en | en |
| dc.subject.other | Anti-Bacterial Agents.therapeutic use | en |
| dc.subject.other | Buruli Ulcer.drug therapy | en |
| dc.subject.other | Humans | en |
| dc.subject.other | Mycobacterium ulcerans.drug effects | en |
| dc.subject.other | Randomized Controlled Trials as Topic | en |
| dc.subject.other | Treatment Outcome | en |
| dc.title | Should antibiotics be given for Buruli ulcer? | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | Lancet | en_US |
| dc.identifier.affiliation | Infectious Diseases | en_US |
| dc.identifier.affiliation | University of Melbourne | en_US |
| dc.identifier.doi | 10.1016/S0140-6736(10)60169-9 | en_US |
| dc.description.pages | 618-9 | en |
| dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/20137806 | en |
| dc.type.content | Text | en_US |
| dc.type.austin | Journal Article | en |
| local.name.researcher | Johnson, Paul D R | |
| item.openairetype | Journal Article | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.languageiso639-1 | en | - |
| crisitem.author.dept | Infectious Diseases | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.